Literature DB >> 17178758

Thrombocytopenia in lupus: baseline C3 as an independent risk factor for relapse.

P D Ziakas, L S Poulou, S Giannouli, A G Tzioufas, M Voulgarelis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17178758      PMCID： PMC1798394          DOI： 10.1136/ard.2006.059758

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.

Authors:  A Ho; S G Barr; L S Magder; M Petri
Journal:  Arthritis Rheum       Date:  2001-10

2.  Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases.

Authors:  Christophe Arnal; Jean-charles Piette; Jean Léone; Bruno Taillan; Eric Hachulla; F Roudot-Thoraval; Thomas Papo; Annette Schaeffer; Philippe Bierling; Bertrand Godeau
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

3.  The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus.

Authors:  M Mosca; W Bencivelli; C Vitali; P Carrai; R Neri; S Bombardieri
Journal:  Lupus       Date:  2000       Impact factor: 2.911

4.  Long-term effectiveness of danazol corticosteroids and cytotoxic drugs in the treatment of hematologic manifestations of systemic lupus erythematosus.

Authors:  J A Aviña-Zubieta; G Galindo-Rodrìguez; I Robledo; J Vela-Ojeda; M Vadillo-Buenfil; A Rosas-Cabral; D Salazar-Exaire
Journal:  Lupus       Date:  2003       Impact factor: 2.911

5.  Effective B cell depletion with rituximab in the treatment of autoimmune diseases.

Authors:  Christian Kneitz; Martin Wilhelm; Hans Peter Tony
Journal:  Immunobiology       Date:  2002-12       Impact factor: 3.144

6.  Lupus thrombocytopenia: clinical implications and prognostic significance.

Authors:  P D Ziakas; S Giannouli; E Zintzaras; A G Tzioufas; M Voulgarelis
Journal:  Ann Rheum Dis       Date:  2005-09       Impact factor: 19.103

7.  Outcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus.

Authors:  Y Nancy You; Ayalew Tefferi; David M Nagorney
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

8.  Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus.

Authors:  D T Boumpas; S Barez; J H Klippel; J E Balow
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

9.  Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil.

Authors:  S Vasoo; J Thumboo; K Y Fong
Journal:  Lupus       Date:  2003       Impact factor: 2.911
  9 in total
  7 in total

Review 1.  The ITP syndrome: pathogenic and clinical diversity.

Authors:  Douglas B Cines; James B Bussel; Howard A Liebman; Eline T Luning Prak
Journal:  Blood       Date:  2009-04-24       Impact factor: 22.113

2.  Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66.

Authors:  Wei Zhang; Suying Dang; Jianhui Wang; Michael A Nardi; Hong Zan; Paolo Casali; Zongdong Li
Journal:  Autoimmunity       Date:  2010-09-09       Impact factor: 2.815

Review 3.  The non-haemostatic role of platelets in systemic lupus erythematosus.

Authors:  Petrus Linge; Paul R Fortin; Christian Lood; Anders A Bengtsson; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

4.  Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective study.

Authors:  Yuan Liu; Shiju Chen; Yuechi Sun; Qingyan Lin; Xining Liao; Junhui Zhang; Jiao Luo; Hongyan Qian; Lihua Duan; Guixiu Shi
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

5.  Up-regulated Complement 3 Production by Toll-like receptor 9/ Transforming Growth Factor-Beta 1/Complement 3 Pathway in Whole Blood Cells of Lupus Thrombocytopenia.

Authors:  Yi Yuan; Ling Zhao; Ning Ma; Zhuang Ye; Zhenyu Jiang; Congqiu Chu
Journal:  Arch Rheumatol       Date:  2017-04-17       Impact factor: 1.472

6.  Evaluation of thrombocytopenia in systemic lupus erythematosus and correlation with different organs damages.

Authors:  Ergeta Ktona; Myftar Barbullushi; Teuta Backa; Alma Idrizi; Vjolica Shpata; Enver Roshi
Journal:  Mater Sociomed       Date:  2014-04-11

Review 7.  Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies.

Authors:  Christina Adamichou; George Bertsias
Journal:  Mediterr J Rheumatol       Date:  2017-03-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.